Patients with JIA showed significantly lower numbers of CD4+CD28-expressing cells as compared with HD (P=0.01), and the difference was more pronounced after 12 months (P=0.004) (Figure 1B). This evidence concerns the gene CD28 and juvenile idiopathic arthritis.